Europe, South America, New Products; Yield Growth Corp Growing at Light Speed


Ryan Allway

September 18th, 2019

App, Exclusive, News, Top News


In the exploding cannabidiol (CBD) market, he who hesitates gets left behind. Companies like The Yield Growth Corp. (CSE: BOSS)(OTCQB: BOSQF) (Frankfurt YG3) are laser-focused and moving with a purpose to plant their flag in global markets forecast by leading cannabis researchers BDS Analytics and Arcview Market Research to exceed $20 billion in less than five years.

CBD, which doesn’t get a person “high” like THC (tetrahydrocannabinol), is a component of cannabis sativa that is widely trumpeted for a bevy of therapeutic benefits from cancer therapy to skincare. Hemp, which became legal in the U.S. at the start of 2019 and is already legal in dozens of countries worldwide, is defined as cannabis sativa containing less than 0.3% THC.

Canada, Yield Growth’s home country, is poised to have its CBD market burst onto the scenes later this year when beverages, edibles and topical CBD products from cannabis become legal.

Click here to receive an investor deck and corporate updates

As it stands, demand for CBD products is booming and the global “green rush” to bring new products to market is on. As evidenced by a non-stop stream of developments and deal flow, The Yield Growth Corp. is in the thick of it with its seasoned management and portfolio of brands, including Urban Juve, Wright & Well and UJ Beverages, as well as its manufacturing unit, W&W Manufacturing, and its strategies business, Thrive Activations.

C$3.7 Million in Deals, More Products on Deck

In addition to its own products, Yield Growth has a successful licensing and white label business that has generated C$3.7 million in signed agreements in 14 months. These agreements demonstrate the breadth of the company’s domain.  One was for three-year exclusive rights to distribute brands and infuse products with CBD and THC in Greece and Cyprus.  Another was for U.S. rights to infuse products with CBD and THC, a third was for international rights to products for a hemp-infused men’s line and a fourth covered European rights to infuse formulas with CBD.

Part of the reason for the success is owed to the company checking all the boxes for current consumers trends in cannabinoids (i.e. CBD, THC) and beauty and wellness products. Yield Growth’s formulas are made from a proprietary extraction technology and are designed to be infused with cannabinoids thought to be beneficial to the body. Giving consumers what they want, all products are made from natural, pure ingredients, are cruelty-free, contaminant-free and contain only high-quality essential oils and botanical extracts.

Analysts at Jeffries are bullish on the CBD health and beauty market, forecasting it to reach $25 billion by 2029 and potentially accounting for 10–15% of global skin care sales.

All told, The Yield Growth Corp. has 26 new products in stability testing with an additional 13 ready to begin testing in the coming weeks. These include six essential oil perfumes, four natural remedy blends with essential oils, foot cream and hand cream made with proprietary hemp root oil and exotic botanicals. Yield Growth has also developed eight men’s products, including four essential oil colognes, shaving cream, hair balm, beard oil, and eight white label versions of men’s products without hemp root oil.

Click here to receive an investor deck and corporate updates

Yield Growth CEO Penny White says that management is negotiating more licensing and distribution agreements that should be finalized by the end of 2019. “Our continued development of our catalogue of hemp formulas for CBD and THC infusion supports our international licensing strategy,” Mrs. White commented in a news release on the activity.

Success in Europe

As it expands its product bag, Yield Growth is also widening its sales channels. Recently, the European Union approved a Compliance Certificate for the Urban Juve Balance Face Moisturizer with Hemp Oil. The face moisturizer is the third Urban Juve product officially registered in Europe, joining the brand’s Anti-Aging Serum and Lip Balm. Another eight products are in the registration process, with expectations approvals will start flowing in within a month.

Furthermore, the company received a trademark from the E.U. protecting its Urban Juve name.  With over 508 million citizens, the E.U. represents a substantial growth opportunity for Yield Growth, so protecting the IP is imperative.

The green light to commercialize the new face moisturizer is perfectly timed, as the product is being featured in Vogue Beauty Highlights in the November issue of UK Vogue, which will put the product in front of the magazine’s 4.1 million readers.

OMG(3)…South America Too

At the end of August, Yield Growth’s subsidiary Urban Juve Provisions, entered an exclusive distribution agreement with Organic Medical Growth OMG3. Per the pact, OMG3 has exclusive distribution rights for Urban Juve products in Colombia and Brazil for a period of five years.

Distribution of the Urban Juve Balance Face Moisturizer with Hemp Oil, Ritual Body Oil and Anti-Aging Serum will first begin in Colombia. Subsequently, registrations will be submitted to get Urban Juve products into more South American countries. The goal is to tap a $32 billion Latin America cosmetics market by extending the distribution agreement to maximize OMG3’s reach and put Urban Juve goods in at least 44,000 retail points which OMB3 has access to.

Click here to receive an investor deck and corporate updates

“With our new distribution alliances in place, Urban Juve products may soon become part of the daily skin care rituals for consumers in Europe and South America,” commented White.

According to OMG3 CEO Jorge Diaz, the future holds big plans for the two companies.  “In addition to creating in-house and co-branded hemp seed and cannabis-based product lines, our strategy is to bring major international brands to the market in the areas of cosmetics, therapeutic and pharmaceutical products,” he said in a statement.

OMG3, a Canadian holding company, owns 100% of Estado Verde S.A.S, a Colombian company that has cannabis-related licenses and permits, including the license for the cultivation of Psychoactive Cannabis (THC) and the License for the cultivation of Non-Psychoactive Cannabis (CBD). OMG3 has secured additional licenses by signing agreements with licensed producers in Colombia.

OMG3 has entered into a joint venture for a 4,000 hectares hemp production in Colombia as it positions itself to become the largest producer and distributor of cannabis products in South America, making it an ideal partner for Yield Growth to scale rapidly across the continent.

Click here to receive an investor deck and corporate updates

Click Here to Receive CFN Media’s Newsletter Every Week in Your Inbox

Disclaimer

CannabisFN.com is not an independent financial investment advisor or broker-dealer. You should always consult with your own independent legal, tax, and/or investment professionals before making any investment decisions. The information provided on https://cannabisfn.com(the ‘Site’) is either original financial news or paid advertisements drafted by our in-house team or provided by an affiliate. CannabisFN.com, a financial news media and marketing firm enters into media buys or service agreements with the companies that are the subject of the articles posted on the Site or other editorials for advertising such companies.  We are not an independent news media provider. We make no warranty or representation about the information including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable. As such, your use of the information is at your own risk. Nor do we undertake any obligation to update the items posted. CannabisFN.com received compensation for producing and presenting high quality and sophisticated content on CannabisFN.com along with financial and corporate news.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading